Brief: Fulgent Genetics Receives Letter From Nasdaq For Not Being In Compliance With The Audit Committee Requirements
23/11/2022 21:20
Nov 23 (Reuters) - Fulgent Genetics Inc FLGT.O :
* FULGENT GENETICS - ON NOV 18, 2022, CO RECEIVED A LETTER
FROM
NASDAQ FOR BEING NO LONGER IN COMPLIANCE WITH THE AUDIT
COMMITTEE REQUIREMENTS
Source: (shorturl.at/mPY78)
Further company coverage: FLGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview